The COVID Plasma Initiative, Agudah’s partners in bringing lifesaving convalescent plasma to the masses, wants higher risk, COVID positive individuals to be aware of a powerful FDA-authorized treatment now available: monoclonal antibody therapy. Monoclonal antibodies are available on an outpatient basis, and work best if administered early, so it’s important to be aware of this development to discuss with your doctor. See for more information.